RNA

RNA

H. Lundbeck A/S and Contera Pharma Form Strategic Alliance to Advance RNA-Based Therapies for Neurological Diseases

H. Lundbeck A/S, a leading Danish pharmaceutical company, and Contera Pharma, a Danish clinical-stage biotech company, have joined forces to accelerate the development of oligonucleotide-based medicines for serious neurological conditions. The strategic research collaboration leverages Lundbeck's extensive neuroscience experience and Contera Pharma's RNA discovery platforms

Genetic research

Breakthrough in Single-Cell Sequencing: Scientists Develop Powerful Tool to Uncover Genetic Links to Complex Diseases

A team of scientists at the European Molecular Biology Laboratory (EMBL) has made a significant breakthrough in single-cell sequencing technology, creating a highly sensitive tool that can help uncover links between genetic variants and complex diseases. Known as single-cell DNA-RNA-sequencing (SDR-seq), this innovative approach allows researchers to study both DNA